BR9811917A - Terapia para staphylococcus aureus - Google Patents

Terapia para staphylococcus aureus

Info

Publication number
BR9811917A
BR9811917A BR9811917-6A BR9811917A BR9811917A BR 9811917 A BR9811917 A BR 9811917A BR 9811917 A BR9811917 A BR 9811917A BR 9811917 A BR9811917 A BR 9811917A
Authority
BR
Brazil
Prior art keywords
staphylococcus aureus
therapy
glycopeptide
methicillin
strains
Prior art date
Application number
BR9811917-6A
Other languages
English (en)
Inventor
Thalia Ioanna Nicas
David Albert Preston
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9811917A publication Critical patent/BR9811917A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"TERAPIA PARA <MU>STAPHYLOCOCCUS AUREUS"<MV><D>. A presente invenção está direcionada a métodos de tratamento de infecções causadas por <MU>Staphylococcus aureus<MV> com sensibilidade reduzida a glicopeptídeo. A invenção é preferencialmente praticada com cepas de <MU>Staphylococcus aureus<MV> que são resistentes à meticilina, tal como a cepa Mu50.
BR9811917-6A 1997-08-22 1998-08-18 Terapia para staphylococcus aureus BR9811917A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22
PCT/US1998/017138 WO1999010006A1 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus

Publications (1)

Publication Number Publication Date
BR9811917A true BR9811917A (pt) 2000-08-15

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811917-6A BR9811917A (pt) 1997-08-22 1998-08-18 Terapia para staphylococcus aureus

Country Status (23)

Country Link
US (1) US5994297A (pt)
EP (1) EP0897725B1 (pt)
JP (1) JP2001513573A (pt)
KR (1) KR100589548B1 (pt)
CN (1) CN1276728A (pt)
AT (1) ATE278413T1 (pt)
AU (1) AU747418B2 (pt)
BR (1) BR9811917A (pt)
CA (1) CA2301589A1 (pt)
CZ (1) CZ299098B6 (pt)
DE (1) DE69826795T2 (pt)
DK (1) DK0897725T3 (pt)
EA (1) EA002602B1 (pt)
ES (1) ES2229454T3 (pt)
HU (1) HU226593B1 (pt)
ID (1) ID24908A (pt)
IL (2) IL134597A0 (pt)
NO (1) NO327042B1 (pt)
NZ (1) NZ502762A (pt)
PT (1) PT897725E (pt)
TR (1) TR200000475T2 (pt)
UA (1) UA59410C2 (pt)
WO (1) WO1999010006A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736860C (en) * 2008-08-30 2020-04-28 Targanta Therapeutics Corp. Methods of treatment using single doses of oritavancin
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
ATE278413T1 (de) 2004-10-15
EA002602B1 (ru) 2002-06-27
WO1999010006A1 (en) 1999-03-04
EP0897725A2 (en) 1999-02-24
DE69826795T2 (de) 2005-10-06
PT897725E (pt) 2004-12-31
AU8913798A (en) 1999-03-16
EP0897725B1 (en) 2004-10-06
NO20000851L (no) 2000-02-21
NO20000851D0 (no) 2000-02-21
IL134597A (en) 2007-09-20
ES2229454T3 (es) 2005-04-16
ID24908A (id) 2000-08-31
KR20010023108A (ko) 2001-03-26
DE69826795D1 (de) 2004-11-11
CZ299098B6 (cs) 2008-04-23
EA200000250A1 (ru) 2000-08-28
NZ502762A (en) 2001-10-26
HUP0002920A3 (en) 2001-12-28
DK0897725T3 (da) 2004-12-13
KR100589548B1 (ko) 2006-06-15
CA2301589A1 (en) 1999-03-04
AU747418B2 (en) 2002-05-16
US5994297A (en) 1999-11-30
CZ2000619A3 (en) 2001-05-16
HUP0002920A2 (hu) 2001-01-29
HU226593B1 (en) 2009-04-28
NO327042B1 (no) 2009-04-06
JP2001513573A (ja) 2001-09-04
CN1276728A (zh) 2000-12-13
EP0897725A3 (en) 2000-02-09
IL134597A0 (en) 2001-04-30
TR200000475T2 (tr) 2000-08-21
UA59410C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
ES2172585T3 (es) Derivado de benzoimidazol.
BRPI0414062A (pt) uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
BR0113637A (pt) Composto, processo para a preparação desse composto, composição farmacêutica que compreende o mesmo, utilização do composto, processo para o tratamento e/ou profilaxia de enfermidade que estão associadas com a atividade de receptor melanocortin-4
BR0215622A (pt) Inibidores da dpiv com base em glutaminila
PT983087E (pt) Composicao de vacina multivalente com veiculo misto
BRPI0512352A (pt) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimiocinas
BRPI0513317A (pt) ciclosporinas para tratar doença de alzheimer
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
EP1037650A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS
ATE128622T1 (de) Behandlungsmittel.
BR0215016A (pt) Piridoquinoxalinas antivirìcas
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
TNSN04035A1 (fr) Azithromycine en dose unique
BRPI0412843A (pt) lactamas substituìdas e uso das mesmas como agentes anticáncer
BR0215067A (pt) Piridoquinoxalinas antivirais
BR0307033A (pt) ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas
BR0314716A (pt) Anticorpos de subunidade alfa de lfa-1 e métodos de uso
BR9811917A (pt) Terapia para staphylococcus aureus
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
BR9812875A (pt) Processos para o tratamento de artrite reumatóide em um mamìfero, e para a fabricação de uma composição terapêutica para o tratamento de artrite reumatóide em um mamìfero, uso de um composto, e, composição farmacêutica

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, OPINO PELO INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O E 13 DA LPI 9279/96).

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.